Overview


According to FutureWise analysis, the market for Injection Pen to reach US$ 40,817.2 million in 2022, and is projected to expand at a CAGR of 7.7% over the forecast period of 2023-2031.

An injection pen, also known as an insulin pen or a prefilled pen, is a medical device that is used to administer medications through subcutaneous injection. It is a convenient and user-friendly device that allows patients to self-administer their medication at home or on the go. An injection pen consists of a disposable or reusable cartridge that contains a pre-measured dose of medication, a needle, and a mechanism for delivering the medication. The pen is often made of plastic and is ergonomically engineered to fit pleasantly in the hand.

To use an injection pen, the patient first attaches a new needle to the pen and then twists the cartridge into place. The patient then primes the pen by dialing the dose and injecting a small amount of medication into the air. Finally, the patient selects the appropriate dose, inserts the needle into the skin, and clicks a button to release the medication. Injection pens are commonly used to administer insulin for the treatment of diabetes alongside other medications such as growth hormones, anticoagulants, and fertility drugs. They offer several advantages over traditional syringes, including more accurate dosing, reduced pain and discomfort, and improved convenience and portability.

FutureWise Market Research has published a report that provides an insightful analysis of Injection Pen Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Injection Pen Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Ypsomed (Switzerland)
  • Sanofi (France)
  • Owen Mumford (UK)
  • Haselmeier (Switzerland)
  • Merck (US)
  • Becton Dickinson and Company (US)
  • Eli Lilly (US)
  • F.Hoffman-La Roche (Switzerland)
  • AstraZeneca (UK)
  • Pfizer (US)
  • Novartis (Switzerland)

Recent developments by key players in Injection Pen Market:

  • In May 2021, With the goal of providing connected insulin pen solutions for individuals with diabetes, Lilly worked globally with top diabetes technology firms. To advance connected solutions and streamline care for people with diabetes, the company entered a strategic international agreement with four businesses: Glooko, Inc., Roche, DexCom, Inc., and myDiabby Healthcare.

The injection pen market has experienced significant growth in recent years and is expected to expand in the coming years. One of the main factors influencing this growth is the increasing incidence of diabetes. According to the International Diabetes Federation, the worldwide prevalence of diabetes is predicted to rise to 700 million by 2045. This indicates a huge potential for the injection pen market, as insulin pens are considered more convenient and less painful than traditional insulin syringes. In addition to the growing demand for injection pens, the market is also being driven by advancements in technology. Manufacturers are constantly improving the design of injection pens to make them more user-friendly and efficient. For example, some pens now have digital displays that provide information on the dose, while others are designed to be more ergonomic and easier to handle. Another factor driving the growth of the injection pen market is the increasing focus on self-administration of medication. Many patients prefer to administer their injections themselves rather than relying on healthcare professionals, and injection pens are well-suited for this purpose. This trend is particularly strong among patients with chronic conditions who require regular injections, as it allows them to manage their condition more effectively and with greater independence.

However, the injection pen market faces some challenges. One of the primary concerns is the cost of these devices. Injection pens can be significantly more expensive than traditional syringes, and this can make them inaccessible to some patients. In addition, there is also the issue of environmental sustainability, as the disposable nature of many injection pens can lead to a significant amount of waste.

By Type

  • Disposable Injection Pen
  • Reusable Injection Pen

By Application

  • Diabetes
    • Insulin
    • Non-insulin
  • Anaphylaxis
  • Osteoporosis
  • Growth hormone deficiency
  • Arthritis
  • Fertility
  • Others

By End User

  • Home Care
  • Hospitals And Clinics

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East And Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. This is due to numerous factors, such as the well-established healthcare infrastructure, the high prevalence of chronic diseases, and the increasing adoption of advanced medical technologies. The United States has the highest prevalence of diabetes in the world, and this has led to an increase in the demand for insulin injection pens. According to the Centres for Disease Control and Prevention (CDC), about 34.2 million people in the United States have diabetes, and this number is expected to grow to 54.9 million by 2030. This has resulted in a significant demand for insulin injection pens, which are preferred over traditional insulin syringes. Moreover, the well-established healthcare infrastructure and favourable reimbursement policies in North America are also contributing to the growth of the injection pen market. The region has a well-developed healthcare system that provides easy access to medical facilities, which has increased the adoption of injection pens among patients. Furthermore, the presence of key market players such as Eli Lilly and Company, Novo Nordisk, and Sanofi is also driving market growth in North America. These companies prioritize developing innovative products and expanding their market presence, which is expected to further boost the growth of the injection pen market in the region. Additionally, based on application; diabetes segment held the highest share of the global market in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global injection pen market by dosage type, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Injection Pen Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Injection Pen Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Injection Pen Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Injection Pen Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Injection Pen Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Disposable Injection Pen
        2. Reusable Injection Pen

  • 8.   Global Injection Pen Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Diabetes
         1.1. Insulin
         1.2. Non-insulin
        2. Anaphylaxis
        3. Osteoporosis
        4. Growth hormone deficiency
        5. Arthritis
        6. Fertility
        7. Others

  • 9.   Global Injection Pen Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Home Care
        2. Hospitals And Clinics

  • 10.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
           5. Europe - Market Share Analysis and Key Regional Players
           6. Asia Pacific - Market Share Analysis and Key Regional Players
           7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)

    •         1. Ypsomed (Switzerland)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Sanofi (France)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Owen Mumford (UK)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Haselmeier (Switzerland)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        16.5 . Merck (US)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        16.6 . Becton Dickinson and Company (US)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Eli Lilly (US)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. F.Hoffman-La Roche (Switzerland)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AstraZeneca (UK)
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pfizer (US)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview  
        10. Novartis (Switzerland)
              11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11